NurExone Biologic Statistics

Total Valuation

TSXV:NRX has a market cap or net worth of CAD 50.63 million. The enterprise value is 47.84 million.

Market Cap	50.63M
Enterprise Value	47.84M

Important Dates

The last earnings date was Monday, April 13, 2026.

Earnings Date	Apr 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TSXV:NRX has 92.05 million shares outstanding. The number of shares has increased by 22.32% in one year.

Current Share Class	92.05M
Shares Outstanding	92.05M
Shares Change (YoY)	+22.32%
Shares Change (QoQ)	+12.50%
Owned by Insiders (%)	5.08%
Owned by Institutions (%)	n/a
Float	87.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	13.39
P/TBV Ratio	13.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.47
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.64

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.04.

Current Ratio	2.63
Quick Ratio	2.25
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-203.97

Financial Efficiency

Return on equity (ROE) is -282.54% and return on invested capital (ROIC) is -169.61%.

Return on Equity (ROE)	-282.54%
Return on Assets (ROA)	-121.15%
Return on Invested Capital (ROIC)	-169.61%
Return on Capital Employed (ROCE)	-204.36%
Weighted Average Cost of Capital (WACC)	6.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.43% in the last 52 weeks. The beta is 0.37, so TSXV:NRX's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-13.43%
50-Day Moving Average	0.63
200-Day Moving Average	0.73
Relative Strength Index (RSI)	40.21
Average Volume (20 Days)	15,709

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.67M
Pretax Income	-8.75M
Net Income	-8.75M
EBITDA	-8.46M
EBIT	-8.67M
Earnings Per Share (EPS)	-0.11

Full Income Statement

Balance Sheet

The company has 2.93 million in cash and 148,081 in debt, giving a net cash position of 2.78 million or 0.03 per share.

Cash & Cash Equivalents	2.93M
Total Debt	148,081
Net Cash	2.78M
Net Cash Per Share	0.03
Equity (Book Value)	3.78M
Book Value Per Share	0.04
Working Capital	2.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.19 million and capital expenditures -75,412, giving a free cash flow of -6.26 million.

Operating Cash Flow	-6.19M
Capital Expenditures	-75,412
Depreciation & Amortization	213,432
Net Borrowing	-30,099
Free Cash Flow	-6.26M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:NRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.32%
Shareholder Yield	-22.32%
Earnings Yield	-17.29%
FCF Yield	-12.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1